Timothy Shaw, the Chief Operating Officer of MariMed Inc., has made notable stock transactions as reported in a recent SEC filing. On October 15, 2026, Shaw acquired 42,657 shares of common stock and disposed of 12,520 shares. Such transactions are significant as they reflect Shaw's ongoing commitment to the company's growth and his personal investment in its future.
MariMed Inc., incorporated in Delaware, operates in the medicinal chemicals and botanical products sector. The company is publicly traded under the ticker MRMD. Its business address is located at 10 Oceana Way, 2nd Floor, Norwood, MA. Shaw has been actively involved in the company, which focuses on the development and distribution of cannabis-related products.
The SEC filing reveals that Shaw's recent transactions included acquiring 42,657 shares at no cost and disposing of 12,520 shares at a price of $0.06 per share. After these transactions, Shaw holds a total of 9,501,259 shares directly and an additional 2,000,000 shares indirectly through the Shaw Family Trust. The trust is managed for the benefit of Shaw's children, with his spouse serving as the trustee.
This update may have implications for MariMed's stakeholders, including employees, investors, and competitors in the medicinal chemicals and botanical products industry. The active participation of executives in stock transactions can reflect confidence in the company's direction and performance.
As for future developments, the filing does not specify what happens next regarding Shaw's stock holdings or any upcoming corporate actions.